⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 9, 2021Biomedical Journal of Scientific & Technical ResearchOpen Access

"Does Inhaled Corticosteroids Increase the Risk of Nontuberculous Mycobacteria Pulmonary Disease: A Meta-Analysis"

View Full Paper

Ask AI

Bookmark

Share

Abstract

This is the authors' abstract. We don't add key points for this paper.

The usage of Inhaled Corticosteroids (ICS) has been showed to increase the risk of pneumonia and tuberculosis. However, whether the usage of ICS increases the risk of Nontuberculous Mycobacteria Pulmonary Disease (NTM-PD) remains unclear. Hence, the aim of the current meta-analysis was to define the risk of NTM-PD with the usage of ICS among chronic respiratory patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jianfeng Li (2021) studied this question.

synapsesocial.com/papers/6a7d6f10da72e8de9c279edd https://doi.org/10.26717/bjstr.2021.39.006363

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Inhaled Corticosteroids and the Risk of Nontuberculous Mycobacterial Infection in Chronic Airway Disease: A Nationwide Population-Based Study2024 · 3 citations
2Inhaled Corticosteroids and Non-Tuberculous Mycobacteria Risk in Patients with COPDCohort Study · 2026 · 1 citations
3Risk of Tuberculosis with the Use of Inhaled Corticosteroids in Delhi/NCR.Original Research · 2026
4Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease and Risk of Acquiring Streptococcus pneumoniae Infection. A Multiregional Epidemiological StudyCohort Study · 2023 · 9 citations
5Inhaled Corticosteroids May Not Affect the Clinical Outcomes of Pneumonia in Patients with Chronic Obstructive Pulmonary Disease2024 · 2 citations